|
1
|
Moini J and Piran P (eds): Chapter 1 -
Histophysiology. In: Functional and Clinical Neuroanatomy. Academic
Press, pp1-49, 2020.
|
|
2
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Pattabiraman DR and Weinberg RA: Tackling
the cancer stem cells-what challenges do they pose? Nat Rev Drug
Discov. 13:497–512. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Bao B, Ahmad A, Azmi AS, Ali S and Sarkar
FH: Overview of cancer stem cells (CSCs) and mechanisms of their
regulation: implications for cancer therapy. Curr Protoc Pharmacol;
Chapter 14: Unit 14 25, 2013.
|
|
5
|
Yan K, Wu Q, Yan DH, Lee CH, Rahim N,
Tritschler I, DeVecchio J, Kalady MF, Hjelmeland AB, Rich JN, et
al: Glioma cancer stem cells secrete Gremlin1 to promote their
maintenance within the tumor hierarchy. Genes Dev. 28:1085–1100.
2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sugiarto S, Persson AI, Munoz EG,
Waldhuber M, Lamagna C, Andor N, Hanecker P, Ayers-Ringler J,
Phillips J, Siu J, et al: Asymmetry-defective oligodendrocyte
progenitors are glioma precursors. Cancer Cell. 20:328–340.
2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
O'Brien CA, Kreso A, Ryan P, Hermans KG,
Gibson L, Wang Y, Tsatsanis A, Gallinger S and Dick JE: ID1 and ID3
regulate the self-renewal capacity of human colon cancer-initiating
cells through p21. Cancer Cell. 21:777–792. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Pece S, Tosoni D, Confalonieri S, Mazzarol
G, Vecchi M, Ronzoni S, Bernard L, Viale G, Pelicci PG and Di Fiore
PP: Biological and molecular heterogeneity of breast cancers
correlates with their cancer stem cell content. Cell. 140:62–73.
2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Okano H: Stem cell biology of the central
nervous system. J Neurosci Res. 69:698–707. 2002.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zarco N, Norton E, Quinones-Hinojosa A and
Guerrero-Cazares H: Overlapping migratory mechanisms between neural
progenitor cells and brain tumor stem cells. Cell Mol Life Sci.
76:3553–3570. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yu SC, Ping YF, Yi L, Zhou ZH, Chen JH,
Yao XH, Gao L, Wang JM and Bian XW: Isolation and characterization
of cancer stem cells from a human glioblastoma cell line U87.
Cancer Lett. 265:124–134. 2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang R and Liu C: All-trans retinoic acid
therapy induces asymmetric division of glioma stem cells from the
U87MG cell line. Oncol Lett. 18:3646–3654. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Shahriyari L and Komarova NL: Symmetric
vs. asymmetric stem cell divisions: An adaptation against cancer?
PLoS One. 8(e76195)2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lathia JD, Hitomi M, Gallagher J, Gadani
SP, Adkins J, Vasanji A, Liu L, Eyler CE, Heddleston JM, Wu Q, et
al: Distribution of CD133 reveals glioma stem cells self-renew
through symmetric and asymmetric cell divisions. Cell Death Dis.
2(e200)2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Berika M, Elgayyar ME and El-Hashash AH:
Asymmetric cell division of stem cells in the lung and other
systems. Front Cell Dev Biol. 2(33)2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Najbauer J, Kraljik N and Nemeth P: Glioma
stem cells: Markers, hallmarks and therapeutic targeting by
metformin. Pathol Oncol Res. 20:789–797. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Jin X, Jin X, Jung JE, Beck S and Kim H:
Cell surface Nestin is a biomarker for glioma stem cells. Biochem
Biophys Res Commun. 433:496–501. 2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zou Q, Yan Q, Zhong J, Wang K, Sun H, Yi X
and Lai L: Direct conversion of human fibroblasts into neuronal
restricted progenitors. J Biol Chem. 289:5250–5260. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wernig M, Tucker KL, Gornik V, Schneiders
A, Buschwald R, Wiestler OD, Barde YA and Brüstle O: Tau EGFP
embryonic stem cells: An efficient tool for neuronal lineage
selection and transplantation. J Neurosci Res. 69:918–924.
2002.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Liu YJ, McIntyre RL, Janssens GE and
Houtkooper RH: Mitochondrial fission and fusion: A dynamic role in
aging and potential target for age-related disease. Mech Ageing
Dev. 186(111212)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Vyas S, Zaganjor E and Haigis MC:
Mitochondria and cancer. Cell. 166:555–566. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Taguchi N, Ishihara N, Jofuku A, Oka T and
Mihara K: Mitotic phosphorylation of dynamin-related GTPase Drp1
participates in mitochondrial fission. J Biol Chem.
282:11521–11529. 2007.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Song M and Dorn GW II: Mitoconfusion:
Noncanonical functioning of dynamism factors in static mitochondria
of the heart. Cell Metab. 21:195–205. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ryan JJ, Marsboom G, Fang YH, Toth PT,
Morrow E, Luo N, Piao L, Hong Z, Ericson K, Zhang HJ, et al:
PGC1α-mediated mitofusin-2 deficiency in female rats and humans
with pulmonary arterial hypertension. Am J Respir Crit Care Med.
187:865–878. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Senft D and Ronai ZA: Regulators of
mitochondrial dynamics in cancer. Curr Opin Cell Biol. 39:43–52.
2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Seo BJ, Yoon SH and Do JT: Mitochondrial
dynamics in stem cells and differentiation. Int J Mol Sci.
19(3893)2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kim D, Sankaramoorthy A and Roy S:
Downregulation of Drp1 and Fis1 inhibits mitochondrial fission and
prevents high glucose-induced apoptosis in retinal endothelial
cells. Cells. 9(1662)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ji WK, Hatch AL, Merrill RA, Strack S and
Higgs HN: Actin filaments target the oligomeric maturation of the
dynamin GTPase Drp1 to mitochondrial fission sites. Elife.
4(e11553)2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yu R, Jin SB, Lendahl U, Nister M and Zhao
J: Human Fis1 regulates mitochondrial dynamics through inhibition
of the fusion machinery. EMBO J. 38(e99748)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chen H, Detmer SA, Ewald AJ, Griffin EE,
Fraser SE and Chan DC: Mitofusins Mfn1 and Mfn2 coordinately
regulate mitochondrial fusion and are essential for embryonic
development. J Cell Biol. 160:189–200. 2003.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Allegra A, Innao V, Allegra AG and
Musolino C: Relationship between mitofusin 2 and cancer. Adv
Protein Chem Struct Biol. 116:209–236. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ruiz A, Alberdi E and Matute C:
Mitochondrial division inhibitor 1 (mdivi-1) protects neurons
against excitotoxicity through the modulation of mitochondrial
function and intracellular Ca2+ signaling. Front Mol
Neurosci. 11(3)2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Cassidy-Stone A, Chipuk JE, Ingerman E,
Song C, Yoo C, Kuwana T, Kurth MJ, Shaw JT, Hinshaw JE, Green DR
and Nunnari J: Chemical inhibition of the mitochondrial division
dynamin reveals its role in Bax/Bak-dependent mitochondrial outer
membrane permeabilization. Dev Cell. 14:193–204. 2008.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Valenti D, Rossi L, Marzulli D, Bellomo F,
De Rasmo D, Signorile A and Vacca RA: Inhibition of Drp1-mediated
mitochondrial fission improves mitochondrial dynamics and
bioenergetics stimulating neurogenesis in hippocampal progenitor
cells from a Down syndrome mouse model. Biochim Biophys Acta Mol
Basis Dis. 1863:3117–3127. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Martinez-Outschoorn UE, Peiris-Pages M,
Pestell RG, Sotgia F and Lisanti MP: Cancer metabolism: A
therapeutic perspective. Nat Rev Clin Oncol. 14(113)2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Caren H, Stricker SH, Bulstrode H, Gagrica
S, Johnstone E, Bartlett TE, Feber A, Wilson G, Teschendorff AE,
Bertone P, et al: Glioblastoma stem cells respond to
differentiation cues but fail to undergo commitment and terminal
cell-cycle arrest. Stem Cell Reports. 5:829–842. 2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Srikanth M, Kim J, Das S and Kessler JA:
BMP signaling induces astrocytic differentiation of clinically
derived oligodendroglioma propagating cells. Mol Cancer Res.
12:283–294. 2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Smith G and Gallo G: To mdivi-1 or not to
mdivi-1: Is that the question? Dev Neurobiol. 77:1260–1268.
2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Takashima Y, Kawaguchi A and Yamanaka R:
Promising Prognosis Marker Candidates on the Status of
Epithelial-Mesenchymal Transition and Glioma Stem Cells in
Glioblastoma. Cells. 8:2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Kim WT and Ryu CJ: Cancer stem cell
surface markers on normal stem cells. BMB Rep. 50:285–298.
2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Fiorillo M, Lamb R, Tanowitz HB, Cappello
AR, Martinez-Outschoorn UE, Sotgia F and Lisanti MP: Bedaquiline,
an FDA-approved antibiotic, inhibits mitochondrial function and
potently blocks the proliferative expansion of stem-like cancer
cells (CSCs). Aging (Albany NY). 8:1593–1607. 2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Roberts ER and Thomas KJ: The role of
mitochondria in the development and progression of lung cancer.
Comput Struct Biotechnol J. 6(e201303019)2013.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Bordt EA, Clerc P, Roelofs BA, Saladino
AJ, Tretter L, Adam-Vizi V, Cherok E, Khalil A, Yadava N, Ge SX, et
al: The Putative Drp1 Inhibitor mdivi-1 is a reversible
mitochondrial complex I inhibitor that modulates reactive oxygen
species. Dev Cell. 40:583–594.e6. 2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Tilokani L, Nagashima S, Paupe V and
Prudent J: Mitochondrial dynamics: Overview of molecular
mechanisms. Essays Biochem. 62:341–360. 2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Semenza GL: Hypoxia-inducible factors:
Coupling glucose metabolism and redox regulation with induction of
the breast cancer stem cell phenotype. EMBO J. 36:252–259.
2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Peiris-Pages M, Martinez-Outschoorn UE,
Pestell RG, Sotgia F and Lisanti MP: Cancer stem cell metabolism.
Breast Cancer Res. 18(55)2016.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Ohka F, Natsume A and Kondo Y: Chapter 15
- Clinical significance of epigenetic alterations in glioblastoma.
In: Epigenetic Cancer Therapy. Gray SG (ed). Academic Press,
Boston, pp339-350, 2015.
|
|
49
|
Garnier D, Renoult O, Alves-Guerra MC,
Paris F and Pecqueur C: Glioblastoma stem-like cells,
metabolic strategy to kill a challenging target. Front Oncol.
9(118)2019.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Safa AR, Saadatzadeh MR, Cohen-Gadol AA,
Pollok KE and Bijangi-Vishehsaraei K: Glioblastoma stem cells
(GSCs) epigenetic plasticity and interconversion between
differentiated non-GSCs and GSCs. Genes Dis. 2:152–163.
2015.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Yuan Y, Yan Z, Miao J, Cai R, Zhang M,
Wang Y, Wang L, Dang W, Wang D, Xiang D, et al: Autofluorescence of
NADH is a new biomarker for sorting and characterizing cancer stem
cells in human glioma. Stem Cell Res Ther. 10(330)2019.PubMed/NCBI View Article : Google Scholar
|
